FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Edoardo Sarubbi

Research Profile

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Living Beings

Physiology

Fermentation

Procedures

Co-author Network

Publications

TOP 3
Edoardo Sarubbi; Federica Monti; Emiliana Corti; Anna Miele; Enrico Selva
Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase.
Ismaela Ciciliato; Emiliana Corti; Edoardo Sarubbi; Stefania Stefanelli; Luciano Gastaldo; Nicoletta Montanini; Michael Kurz; Daniele Losi; Flavia Marinelli; Enrico Selva
Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization.
Dino Zanette; Adolfo Soffientini; Cristina Sottani; Edoardo Sarubbi
Evaluation of phenylboronate agarose for industrial-scale purification of erythropoietin from mammalian cell cultures.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Edoardo Sarubbi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Edoardo Sarubbi; Federica Monti; Emiliana Corti; Anna Miele; Enrico Selva
Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase.
European journal of biochemistry / FEBS 2004;271(15):3146-54.
2004: Ismaela Ciciliato; Emiliana Corti; Edoardo Sarubbi; Stefania Stefanelli; Luciano Gastaldo; Nicoletta Montanini; Michael Kurz; Daniele Losi; Flavia Marinelli; Enrico Selva
Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization.
The Journal of antibiotics 2004;57(3):210-7.
2003: Dino Zanette; Adolfo Soffientini; Cristina Sottani; Edoardo Sarubbi
Evaluation of phenylboronate agarose for industrial-scale purification of erythropoietin from mammalian cell cultures.
Journal of biotechnology 2003;101(3):275-87.
1998: D Zanette; W Dundon; Adolfo Soffientini; Cristina Sottani; Flavia Marinelli; A Akeson; Edoardo Sarubbi
Human IL-1 receptor antagonist from Escherichia coli: large-scale microbial growth and protein purification.
Journal of biotechnology 1998;64(2-3):187-96.
1997: Stefania Stefanelli; Emiliana Corti; Nicoletta Montanini; M Denaro; Edoardo Sarubbi
Inhibitors of type-I interleukin-1 receptor from microbial metabolites.
The Journal of antibiotics 1997;50(6):484-9.
1997: H Schreuder; C Tardif; S Trump-Kallmeyer; Adolfo Soffientini; Edoardo Sarubbi; A Akeson; T Bowlin; Stephen D Yanofsky; Ronald W Barrett
A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.
Nature 1997;386(6621):194-200.
1997: C Cappellano; F Monti; Margherita Sosio; Stefano Donadio; Edoardo Sarubbi
Natural kirromycin resistance of elongation factor Tu from the kirrothricin producer Streptomyces cinnamoneus.
Microbiology (Reading, England) 1997;143 ( Pt 2)():617-24.
1996: Edoardo Sarubbi
Particle concentration fluorescence as an alternative to radioactivity for cytokine receptor binding assays.
Journal of immunological methods 1996;198(2):113-8.
1996: Edoardo Sarubbi; S D Yanofsky; Ronald W Barrett; M Denaro
A cell-free, nonisotopic, high-throughput assay for inhibitors of type-I interleukin-1 receptor.
Analytical biochemistry 1996;237(1):70-5.
1995: H Schreuder; C Tardif; Adolfo Soffientini; Edoardo Sarubbi; A Akeson; Terry Bowlin; S Yanofsky; Ronald W Barrett
Crystals of soluble interleukin-1 receptor complexed with its natural antagonist reveal a 1:1 receptor-ligand complex.
FEBS letters 1995;373(1):39-40.
1995: S Stefanelli; L Cavaletti; Edoardo Sarubbi; E Ragg; L Colombo; E Selva
GE20372 factor A and B. New HIV-1 protease inhibitors, produced by Streptomyces sp. ATCC 55925.
The Journal of antibiotics 1995;48(4):332-4.
1995: H A Schreuder; J M Rondeau; C Tardif; Adolfo Soffientini; Edoardo Sarubbi; A Akeson; Terry Bowlin; S Yanofsky; Ronald W Barrett
Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline.
European journal of biochemistry / FEBS 1995;227(3):838-47.
1993: Edoardo Sarubbi; M Denaro
Epitope mapping of a monoclonal antibody which binds HIV-1 Gag and not the Gag-derived proteins.
FEBS letters 1993;335(3):335-7.
1993: Edoardo Sarubbi; P F Seneci; Michael R Angelastro; Norton P Peet; M Denaro; K Islam
Peptide aldehydes as inhibitors of HIV protease.
FEBS letters 1993;319(3):253-6.
1991: S Stella; G Saddler; Edoardo Sarubbi; L Colombo; S Stefanelli; M Denaro; E Selva
Isolation of alpha-MAPI from fermentation broths during a screening program for HIV-1 protease inhibitors.
The Journal of antibiotics 1991;44(9):1019-22.
1991: Edoardo Sarubbi; M L Nolli; F Andronico; S Stella; G Saddler; E Selva; Antonio Siccardi; M Denaro
A high throughput assay for inhibitors of HIV-1 protease. Screening of microbial metabolites.
FEBS letters 1991;279(2):265-9.
1989: Edoardo Sarubbi; M L Nolli; F Robbiati; Adolfo Soffientini; F Parenti; G Cassani
The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1.
Thrombosis and haemostasis 1989;62(3):927-33.
1989: A Corti; Edoardo Sarubbi; Adolfo Soffientini; M L Nolli; A Zanni; M Galimberti; F Parenti; G Cassani
Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase.
Thrombosis and haemostasis 1989;62(3):934-9.
1989: Pier Giorgio Righetti; B Barzaghi; Edoardo Sarubbi; Adolfo Soffientini; G Cassani
Charge heterogeneity of recombinant pro-urokinase and urinary urokinase, as revealed by isoelectric focusing in immobilized pH gradients.
Journal of chromatography 1989;470(2):337-50.